Publications

Overcoming rejection – Reducing risk of organ rejection after transplant operations

LGC has developed the first commutable matrix reference material for the immunosuppressant drug tacrolimus, in order to improve therapeutic drug monitoring following an organ transplant.

To download this case study click on the link below. For further information about topics covered by the case study, please contact the NMS helpdesk at LGC.